This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
New generic oral antiviral drugs for Hepatitis C has come as a major relief for almost 12 to 18 million Indians affected by the disease.
The prices are about one hundredth of that in developed countries like the US and Japan.
While one tablet of sofosbuvir costs around Rs 30,000 in Japan, it comes for around Rs. 350 in India; For daclatasvir, the difference is around Rs.10,000 and Rs. 135, and for the combination drug of sofosbuvir and ledipasvir, it is Rs.40,000 and Rs.500. The prices are even higher in markets like the US, according to doctors of both countries that HT talked to.
Sofosbuvir, daclatasvir, and ledipasvir are generic names of the medicines for treatment of the disease.